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PURPOSE. Oxygen-induced retinopathy (OIR) is the most widely used model for ischemic
retinopathies such as retinopathy of prematurity (ROP), proliferative diabetic retinopathy
(PDR), and retinal vein occlusion (RVO). The purpose of this study was to perform the most
comprehensive characterization of OIR by a recently developed technique, sequential
window acquisition of all theoretical mass spectra (SWATH-MS) proteomics.
METHODS. Control and OIR retina samples collected from various time points were subjected
to SWATH-MS and detailed data analysis. Immunohistochemistry from mouse retinas as well as
neovascular membranes from human PDR and RVO patients were used for the detection of
the localization of the proteins showing altered expression in the retina and to address their
relevance to human ischemic retinopathies.
RESULTS. We report the most extensive proteomic profiling of OIR to date by quantifying
almost 3000 unique proteins and their expression differences between control and OIR
retinas. Crystallins were the most prominent proteins induced by hypoxia in the retina, while
angiogenesis related proteins such as Filamin A and nonmuscle myosin IIA stand out at the
peak of angiogenesis. Majority of the changes in protein expression return to normal at P42,
but there is evidence to suggest that proteins involved in neurotransmission remain at
reduced level.
CONCLUSIONS. The results reveal new potential therapeutic targets to address hypoxia-induced
pathological angiogenesis taking place in number of retinal diseases. The extensive proteomic
profiling combined with pathway analysis also identifies novel molecular networks that could
contribute to the pathogenesis of retinal diseases.
Keywords: proteomics, mass spectrometry, oxygen induced retinopathy, angiogenesis,
hypoxia
Retinal ischemic diseases, such as retinopathy of prematurity(ROP), diabetic retinopathy (DR), and retinal vein occlu-
sion (RVO) are major causes of visual impairment and blindness
in industrialized countries.1–5 The most prominent pathological
features of these diseases are abnormal angiogenesis and
enhanced vascular permeability, which leads to vision loss.
However, inflammation, oxidative stress, and neuronal dysfunc-
tion are also contributing to the pathogenesis of ischemic
retinal diseases.
The mouse oxygen-induced retinopathy (OIR) model6 is a
well-established animal model of ROP, which shares many
hallmarks with human proliferative diabetic retinopathy (PDR)
as well as neovascular RVO. Thus, it is the most widely used
model to study retinal ischemic diseases.7 OIR is characterized
by hyperoxia-induced vessel loss from retina followed by
regrowth of vasculature and formation of preretinal neovascu-
larization upon return to normoxia. It is considered mainly as
an angiogenesis model, but neuronal damage and pathological
effects on retinal glia have also been reported in OIR.8
Due to complex interactions between vascular, neuronal,
glial, and immune cells in retinal vascular disorders, it is
important to study changes in whole retinal tissue simulta-
neously to gain more information about the pathogenesis of
retinal disease. Mass spectrometry (MS)-based proteomic
profiling has become a widely-used approach to assess the
development and the progression of diseases.9 Full proteome-
based approach provides an unbiased method to study changes
in proteins involved in any given tissue, organ, or disease. As
the OIR model is considered as the most representative model
for a large number of neovascular human retinal diseases, there
has been considerable interest to characterize OIR with MS-
based approaches. Previous studies on rodent OIR proteome
have been done with Isobaric Tags for Relative and Absolute
Quantitation (iTRAQ) MS approach,10,11 and with ion-current-
based MS1 quantification approach (ICB) from rat retinas.12
With these methods, it has been possible to quantify almost
30010,11 and 1300 proteins from retinas,12 respectively. In this
study, a recently developed technique,13 sequential window
acquisition of all theoretical mass spectra (SWATH)-MS proteo-
mics, was used to compare proteomes of mouse OIR model
with control retina. SWATH-MS is an MS method that combines
data-independent acquisition (DIA) and data-dependent acqui-
Copyright 2018 The Authors
iovs.arvojournals.org j ISSN: 1552-5783 3294
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/937362/ on 08/21/2018
sition (DDA), which iTRAQ and targeted data analysis uses,
extending the throughput of proteins and data completeness.14
Here we report the most extensive proteomic profiling of OIR
to date by relatively quantifying almost 3000 unique proteins.
The novel methodology used in the present study also allowed
the temporal profiling of OIR proteome for the first time, while
in the previous studies, it has been possible to compare the
protein levels in a single time point. Immunohistochemistry
was used to study the localization of differently expressed
proteins in control and OIR retinas, as well as in neovascular
membranes obtained from PDR and RVO patients to address
the relevance of these findings to human ischemic retinopa-
thies.
MATERIALS AND METHODS
Mouse OIR Model
WT C57BL/6 mice were used for the study. Mice were housed
under standard conditions with 12-hour dark/12-hour light
cycle and fed with standard laboratory pellets and water ad
libitum. The OIR model was generated as described in detail
previously.6,15–17 Briefly, to induce OIR, the pups at postnatal
day 7 (P7) and their nursing mothers were exposed to 75%
oxygen (ProOx P110 oxygen controller; Biospherix Ltd.,
Parish, NY, USA) for 5 days until P12 when they were returned
to normal room air. Mice were sacrificed and retinas collected
at P13 (early hypoxic phase), at P17 (late hypoxic phase and
the peak of neovascularization), and at P42 (after vascular
recovery) to assess the effect of OIR on retinal proteome.
Control animals were housed under normal room air condi-
tions and retinas were harvested at corresponding days. The
study design is illustrated in Figure 1. As postnatal weight gain
has been shown to affect outcome in the OIR model,7 only the
pups weighing between 6.3 and 7.5 g at P17 were included in
the study. All animal experiments were conducted under ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research guidelines in accordance with protocols approved by
the National Animal Ethics Committee of Finland.
For the proteomic analysis, eye balls were harvested into
cold PBS and retinas were dissected immediately under the
dissection microscope, and retinas were snap frozen with
liquid nitrogen. Samples were stored in 708C until sample
preparation.
Proteomics
Chemicals and Materials. Acetonitrile (ACN), formic acid
(FA), water (UHPLC-MS grade), triethylammonium bicarbonate
buffer 1M (TEAB), sodium dodecyl sulfate (SDS), iodoaceta-
mide (IAA), trifluoroacetic acid (TFA), ammonium bicarbonate
(ABC), and urea were all purchased from Sigma Aldrich Corp.
(St. Louis, MO, USA). Radioimmunoprecipitation assay (RIPA)
cell lysis buffer, a cocktail (Halt Protease Inhibitor Cocktail),
and sample clean up tips (C18) were from Thermo Fisher
Scientific (San Jose, CA, USA). A kit (Bio-Rad DC) and bovine
serum albumin standard were purchased from Bio-Rad
(Hercules, CA, USA), and 30 kDa molecular weight cut off
(MWCO) centrifugal devices were from PALL (Port Washing-
ton, NY, USA).
FIGURE 1. Outline of the study. OIR was generated by exposing the mice pups for 75% oxygen for 5 days from P7 to P12. Control and OIR retinas
were collected to SWATH-MS analysis, while some retinas from each litter were used for histological examination to confirm the changes in the
vasculature in OIR. Retinal vasculature was stained with Isolectin GS-IB4. OIR samples were collected during hypoxia at P13 when central retina is
avascular, at P17 when retina is partially revascularized and the neovascularization (preretinal tufts) peaks, and at P42 when retina is completely
revascularized and neovascularization is regressed. Age-matching control samples were collected from mice housed in normal room air. P13 n¼ 5;
P17 n ¼ 9; P42 n ¼ 6; P13 OIR n¼ 5; P17 OIR n¼ 6; P42 OIR n ¼ 7.
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Sample Preparation and Analysis. Proteins were ex-
tracted by submerging tissues to 300 lL RIPA cell lysis buffer in
ice and homogenized using plastic pestles and centrifuged
(2400g/min, 5 minutes). After centrifugation, tissue samples
were set in cold ultrasonic bath for 5 minutes and incubated on
ice for 25 minutes. After incubation, samples were centrifuged
at 21,000g for 20 minutes and the supernatant containing the
proteins were transferred to new tube. Protein concentration
was measured using Bio-Rad DC protein quantification kit.
Average amount of protein recovered per sample was 253.8 6
32.9 lg (6 SD). Fifty micrograms of total protein was taken
from each sample to tryptic digestion.
Samples were then subjected to reduction, alkylation, and
tryptic digestion. These steps were performed as described in
detail in the Supplementary Methods. For MS analysis, the
samples were eluted to the same concentration and 4 lg
sample was injected into NanoLC-TripleTOF (Sciex 5600þ).
Two replicate MS analyses were produced from each sample.
Analysis of the samples was done by NanoLC-TripleTOF MS
using SWATH acquisition as described in the Supplementary
Methods.
Protein Identification and Quantification. As part of
the SWATH analysis method, a relative protein quantification
library, consisting of >3500 retinal proteins, was created using
retina samples from this study. Overall library consisted of 32
different samples and 45 data-dependent analysis (DDA) runs
with same LC gradient and instrument settings that were used
for SWATH analyses. Library was created using Protein Pilot 4.7
(Sciex, Redwood City, CA, USA) and all DDA runs spectra were
identified against Mouse UniprotKB/SwissProt protein library.
Quantification was done by Peak Viewer and Marker Viewer
(Sciex). False discovery rate (FDR) 1% was used in the library
creation and only distinctive peptides were used in the
quantification. Retention time calibration was done for all
samples using 15 representative peptides from two different
proteins, a-enolase (ENO1) and albumin (ALB). Five transitions
per peptide and 1 to 15 peptides were used for protein
quantification calculations. All statistically significant (adjusted
P < 0.05) and other interesting proteins discussed further were
subjected to manual inspection of peptides. This consisted of
checking correct peak selection in the chromatogram (FDR 1%,
99% peptide confidence level), sufficient signal to noise ratio
inspection (>7), and chromatogram inspection in relation to
library chromatogram. Also, variation of replicate MS analysis
results was calculated as means to all samples/protein. All
peptides were eliminated from results processing if manual
inspection requirements were not fulfilled. Proteins with
missing values were excluded from consideration. Checked
proteins whose quantification was based on only one specific
peptide are marked with †-symbol to the graphs and tables.
Most of these proteins were small proteins, meaning a small
likelihood of having more than one specific peptide identified
for quantification.
Western Blotting. Retinal protein lysates were run into
SDS PAGE gels, transferred to polyvinylidene diflouride (PVDF)
membranes, and immunoblotted with anti-Flna, anti-Myh9, and
anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) anti-
bodies, as described in the Supplementary Methods.
Immunohistochemistry. For the retinal flat mount
analysis, the eye balls were harvested at P13, P17, and P42.
Eye balls were fixed with 4% paraformaldehyde (PFA) for 1
hour where after retinas were dissected, stained with isolectin
(Isolectin GS-IB4; Invitrogen, Carlsbad, CA, USA), flat mounted,
and imaged via confocal microscope (LSM 700; Carl Zeiss,
Oberkochen, Germany).
For immunohistochemistry, the eye balls were harvested,
fixed with 4% PFA for 4 hours, and processed for paraffin
embedding. Five-micrometer thick sections were subjected to
antigen retrieval (Tris-EDTA, pH9), blocked and incubated
either with anti-Filamin-A antibody (Cat#ab76289; Abcam,
Cambridge, UK) or anti-Myh9 antibody (Cat#11128-1-AP;
Proteintech, Rosemont, IL, USA) followed by horseradish
peroxidase (HRP) conjugated secondary antibodies. For
immunofluorescence (IF) double-staining, sections were pre-
treated with trypsin and incubated with anti-Myh9 antibody
(Proteintech) and anti-CD31 (Cat#550274; BD BioSciences, San
Jose, CA, USA) or anti-Myh9 and anti-NG2 (provided by W.
Stallcup, Sanford Burnham Prebys Medical Discovery Institute,
La Jolla, CA, USA),18 followed by appropriate Alexa Fluor dye
conjugated secondary antibodies (Invitrogen). Samples were
imaged via confocal microscope (LSM700; Carl Zeiss).
Neovascular membranes were obtained from nine PDR and
one RVO patients, who were undergoing pars plana vitrecto-
my. At the time of surgery, patients’ mean age was 37 years
(range, 27–56 years) and mean duration of diabetes was 26
years (range, 21–32 years). The protocol for collecting human
tissue samples was approved by the institutional review boards
of the Pirkanmaa Hospital District, and the study was
conducted in accordance with the Declaration of Helsinki.
All patients gave written informed consent. The fibrovascular
membranes were isolated, grasped with vitreous forceps, and
pulled out through a sclerotomy. Samples were immediately
fixed with 10% formalin for 3 hours, transferred to 70%
ethanol, and processed for paraffin embedding and immuno-
histochemistry. Samples were stained with anti-Myh9 antibody
(Proteintech) and anti-HSA (cat #LS-B6178; LSBio, Seattle, WA,
USA) followed by HRP conjugated secondary antibodies.
Statistical Analysis. Proteins were quantified and log2-
transformation was applied to the data, and in addition,
geometric means of replicate MS analyses were taken. No
further normalization was deemed necessary. The quality of
the replicate MS analyses was analyzed by analyzing the
intraclass correlation (ICC), and Spearman’s rank correlation
was used to generate P values in permutation tests (n ¼ 1000
permutations / replicate MS analyses).
Principal component analysis (PCA) was used to cluster the
samples based on full proteomic profiles. Two-sample t-test
was used to analyze differences between the relative protein
expression levels of control and OIR retinas. Levene’s test was
performed for the statistically significant proteins (after P value
adjustment), and two proteins had a P value < 0.05. For these
proteins, the statistical significance was checked with Wilcox-
on rank sum test.
Benjamini-Hochberg adjustment was used to account for
multiple testing, and the significance threshold, a, was set at
0.05. All statistical analyses for the proteomics data were
performed using R software version 3.2.3 (R Core Team,
Foundation for Statistical Computing, Vienna, Austria) and IPA
software (IPA; QIAGEN, Redwood City, CA, USA).
RESULTS
Protein Profiles Are Associated With the
Developmental Stage of the Retina
To study the protein profiles of control and OIR retinas, we
first confirmed the development of OIR by staining the
vasculature from retinal flat mounts at different time points
(Fig. 1). With SWATH-MS quantification, we then used a library
of 121,145 peptides from 32 samples, corresponding to
1,576,233 identified spectra in an assembly of 3316 protein
groups using FDR of 1.0%. From this library, 2944 proteins had
distinct peptides sequences with matching spectra to SWATH-
MS analysis, and these proteins were quantified in all samples.
Out of 2944 relatively quantified proteins, the quantification
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was based on more than one peptide in 2177 proteins. Proteins
quantified using a single peptide are marked in the figure
legends. The replicate MS analysis quality checks showed that
the ICC coefficient was 0.99 between the replicates. Permu-
tation tests using Spearman’s correlation showed that 94.4% of
the replicate MS analyses had a P < 0.05, which suggests that
they were of excellent quality.
For the proteomic data, we first wanted to evaluate the
underlying patterns and differences between time points. PCA
was performed for the whole data, and the plotting results
based on the first two components suggested that there was a
clear division between different time points of both control
and OIR retina samples (Fig. 2). In addition, some separation
was seen between control and OIR retinas at P13 and P17. At
P42, the two groups were overlapping and there was no longer
detectable division between control and OIR protein profiles.
Taken together, the strongest cause for the differences in
protein expression levels based on the first component
appears to be the developmental stage of mouse retina.
Differential Expression Analysis of OIR and
Control Retinas: The Induction of Crystallins by
Hypoxia at P13 and Angiogenesis-Related Proteins
at P17
Next, we performed differential expression analysis in order to
identify proteins, which differed between control and OIR
samples in specific time points. Comparison of control and OIR
samples resulted in 364 differentially expressed proteins at
P13, 387 at P17, and 104 at P42 (P < 0.05) prior to further P
value adjustments. These proteins are listed in Supplementary
Table S1 for P13, Supplementary Table S2 for P17, and
Supplementary Table S3 for P42.
P value adjustments to account for the multiple hypotheses
testing reduced the number of statistically significant results
and led to 17 differentially expressed proteins at P13, 22 at
P17, and none at P42. To visualize the differential expression in
response to hypoxia at P13, P17, and P42, volcano plots are
shown (Figs. 3A–C). In addition to visualizing the statistically
significant (adjusted P < 0.05) proteins and their associated up-
or downregulation, the plots revealed a highly upregulated
group of proteins in response to hypoxia at P13 OIR (Fig. 3A).
These proteins are crystallins, including members of a-, b-, and
c-crystallins. The expression levels of individual crystallins did
not reach statistically significant difference after P value
adjustment, but they are the most upregulated proteins in
the whole data according to fold change (FC) (log2 FC 2.67–
4.32) (Supplementary Fig. S1 and Supplementary Table S1). It
is also noteworthy that based on FC alone, the most
upregulated (log2 FC > 2) proteins at the peak of the
FIGURE 2. PCA shows distinct clustering of retinal proteins based on
the developmental stage of the retina. The protein profiles obtained
from control and OIR retinas are clearly different at P13 (red), P17
(green), and P42 (blue). Control () and OIR (m) samples are also
separated quite distinctively within the clusters at P13 and P17, but no
more at P42.
FIGURE 3. Volcano plots of the differential expression analysis. The log2 FC is displayed in the x-axis and the P value (log10) is shown in the y-axis
and hence, proteins in the top right and left corners are the most interesting ones as they represent the most heavily upregulated or downregulated
proteins in OIR. Points with darker gray are proteins with an adjusted P value < 0.05. (A) At P13, there were 17 proteins with adjusted P < 0.05
and these were all downregulated in OIR samples. The blue cluster (A) shows the crystallins, which were noticeably upregulated although most
members of the crystallin family did not reach threshold for statistical significance. (B) Altogether 22 proteins showed differential expression based
on their adjusted P < 0.05 in OIR at P17. In general, more proteins were upregulated in OIR samples compared to control retinas at P17 than at
other studied time points. (C) One protein (Cartpt) was deemed statistically significant (based on the adjusted P value) at P42, but was discarded
from the results during the manual peak evaluation.
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angiogenesis (at P17), were vitamin D-binding protein (Gc), a-
2-HS-glycoprotein/fetuin-A (Ahsg), a-1-antitrypsin 1-4 (Serpi-
na1d), and carboxylesterase 1C (Ces1c) (nonadjusted P <
0.05) (Supplementary Table S2). Of the aforementioned
proteins, one (Ahsg) was also statistically significant (Fig. 3B).
At P42, cocaine- and amphetamine-regulated transcript protein
(Cartpt) was initially found to be statistically significant after
the P value adjustment (Fig. 3C). However, this change was
deemed unreliable after manual peak checking.
The heat maps of the statistically significant results at P13
and P17 show the relative expression of the proteins and the
differences between control and OIR samples (Figs. 4A, 4B).
Four proteins had statistically significant difference at P13
(absolute log2 FC > 0.585; i.e., FC above 1.5: abs(log2(1.5)):
glutamine synthetase (Glul), guanylyl cyclase GC-E (Gucy2e),
cGMP-gated cation channel a-1 (Cnga1) and rod outer segment
membrane protein 1 (Rom1) (Fig. 4). Substantially more
proteins showed similar difference (log2 FC > abs(log2(1.5))
in the expression levels between OIR and control at P17: Ahsg,
annexin A2 (Anxa2), transgelin-2 (Tagln2), cell surface
glycoprotein MUC18 (Mcam), tropomyosin a-4 chain (Tpm4),
filamin-B (Flnb), protein SON (Son), Gpx1, vinculin (Vcl),
myosin-9 (Myh9), serpin H1 (Serpinh1), filamin-A (Flna),
moesin (Msn), and annexin A6 (Anxa6) (Figs. 4B, 5). Similarly,
downregulated proteins at P17 OIR were Glul, prosaposin
receptor GPR37 (Gpr37), sideroflexin-5 (Sfxn5), and synaptic
vesicle glycoprotein 2A (Sv2a) (Fig. 4B). Significantly down-
regulated proteins both at P13 OIR and P17 OIR were Glul and
retinaldehyde-binding protein-1 (Rlbp1). The mean expression
values are illustrated in Figure 5 and in Supplementary Figure
S2 for all of the statistical significant proteins (adjusted P value
< 0.05). There were no proteins with altered expression level
at P42 OIR after P value adjustment.
Hypoxia Induces Filamin-A Cleavage at P17 OIR
In order to validate the results from proteomic analysis of
OIR, Flna and Myh9 were selected for immunoblotting.
Immunoblotting with C-terminal anti-Flna antibody con-
firmed increased Flna expression at P17 OIR (4.6-fold
compared to P17 control). In hypoxia, Flna is cleaved by
calpain-proteases to generate 90 kDa C-terminal fragment
that interacts with hypoxia-inducible factor-1a (HIF-1a) and
promotes angiogenesis.43 The expression of C-terminal
fragment of Flna (FlnaCT) generated in the presence of
hypoxia was increased 14-fold in OIR at P17 OIR (Figs. 5C,
5D). Next, the expression of Myh9 was studied in OIR by
immunoblotting. A 9.6-fold increase in the expression of the
Myh9 was seen at P17 OIR when compared to the expression
at P17 controls (Figs. 5E, 5F).
Filamin-A and Myh9 Expression Is Increased in the
Angiogenic Blood Vessels in OIR Retinas
While proteomic analysis and immunoblotting revealed an
increased expression of Flna and Myh9 at P17 OIR, immuno-
histochemical stainings confirmed substantially stronger ex-
pression of these proteins from P17 OIR retinas than from
control retinas (Fig. 5G). We observed marked increase in Flna
expression in preretinal tufts and blood vessels of inner retina
in the OIR retinas in comparison to controls. Also, a faint
staining is seen in others cell types, presumably retinal
neurons, but the expression level in neurons looks identical
in control and OIR retinas. Thus, the induction of Flna
expression seen in OIR at P17 is clearly from the angiogenic
blood vessels.
Myh9 expression in OIR retinas was studied in detail by
performing double-immunofluorescent stainings for Myh9 and
endothelial cell (CD31), and pericyte (NG2) markers. Strong
Myh9 expression was localized to endothelial cells and
pericytes in OIR at the peak of the angiogenesis at P17. All
endothelial cells expressed Myh9, while there were some
pericytes negative for Myh9 at P17 OIR (Fig. 6).
Abundant Expression of Myh9 on Neovascular
Membranes From Human PDR Patients
Generally, the expression levels of Myh9 reflect the overall
stiffness of the tissue.19–21 The increased matrix stiffness
destabilizing endothelial cell–cell junctions impairs the
endothelial barrier function and leads to enhanced endothe-
lial permeability.22 We next studied Myh9 and human serum
albumin (HSA; i.e., marker of vascular leakage) expression on
human fibrovascular membranes (using adjacent tissue
sections) from vitrectomized patients with PDR and RVO.
Strong fibrosis formation leads to retinal traction and
ultimately to retinal detachment in RVO. The samples
represent the end stage of these diseases, where substantial
amount of fibrosis has been formed, but the samples still
contain also regions with active pathologic angiogenesis.
When only a faint expression of Myh9 is seen outside of the
blood vessels, the intensity of Myh9 staining in blood vessels
is also faint one (Fig. 7). Strong Myh9 expression was seen
both in the blood vessels and in the matrix in some samples
and then HSA starts to accumulate in the tissue. Particularly
strong Myh9 expression was seen all over the fibrotic
membrane in the RVO sample that contains blood vessels
and massive scarring (Fig. 7). Comparison of Myh9 expression
to HSA expression showed a strong positive correlation
between the two; more Myh9 expressing cells (increased
matrix stiffness) outside the blood vessels, more Myh9
expression (contractility and destabilization of cell–cell
junctions) in the blood vessels and the more abundant
vascular leakage outside the blood vessels (Fig. 7).
Ingenuity Pathway Analysis (IPA) Identifies Angio-
genesis and Transforming Growth Factor-b1 (TGF-b1)
Pathway As the Most Prominent Features of OIR at P17.
In order to connect the differentially expressed proteins to
specific pathways and biological functions, pathway analysis
was performed using IPA on the proteins showing statisti-
cally significant differences in their expression between
control and OIR retinas (adjusted P < 0.05) in each time
point. The top canonical pathways connected to the 17
proteins at P13 (Fig. 4A) were phototransduction pathway (P
¼ 4.95e-10) (Supplementary Fig. S3), protein kinase A
signaling (P ¼ 2.29e-04), and glutamine biosynthesis I (P ¼
8.05e-04). There were no unbiased activation scores <2 or
> 2 for disease and biological functions or for upstream
regulators.
For the 22 proteins identified in differential expression
analysis at P17 (Fig. 4B), the top canonical pathways were actin
cytoskeleton signaling (activation score ¼ 2.1, P ¼ 3.18e-06),
ILK signaling (activation score ¼ 1, P ¼ 4.61e-05), and
glutamine biosynthesis I (P ¼ 1.04e-03). We then performed
the disease and biological function enrichments analyses,
which showed both necrosis and cell death reduced (P ¼
7.25e-04 and P ¼ 6.94e-05, both with activation score  2),
while angiogenesis was increased (P ¼ 2.53e-04, activation
score ‡ 2). According to IPA, the increase in angiogenesis was
due to the upregulation of Anxa2, Flna, Flnb, Gpx1, Mcam,
Myh9, and Serpinh1. For further classification, upregulated
proteins Tagln2, Vcl, Mcam, Flnb, ATP-dependent 6-phospho-
fructokinase (Pfkp), Myh9, and Flna are proteins involved in
cell–cell adhesion (Amigo2). In addition, the upstream
regulator analysis identified TGF-b1 (Tgfb1), MAP kinase-
interacting serine/threonine-protein kinase 1 (Mknk1), and
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MKL/myocardin-like protein 2 (Mkl2) as potential upregulated
enhancers of angiogenesis (for all P < 0.001 and activation
score ‡ 2), while brain-derived neurotrophic factor (Bdnf),
Krueppel-like factor 3 (Klf3), and Myc proto-oncogene protein
(Myc) were inhibited (for all P < 0.001 and activation score 
2) (Supplementary Table S4).
Marginal Long-Term Changes in the Protein
Expression Persist in OIR Retina
There were no proteins with statistically significant difference
in the expression levels between OIR and control retina after P
value adjustment at P42. We then performed the IPA analysis
FIGURE 4. Heat maps of differentially expressed proteins between control and OIR retinas. Retinas from control and OIR mice were harvested at
P13, P17, and P42 and processed to MS-SWATH analysis. The colors display discretized values of the relative protein expression levels as described
in the color key legend. (A) Seventeen proteins downregulated during hypoxia at P13 OIR retinas compared to control retinas at P13 (adjusted P
value < 0.05). (B) Twenty-two proteins up- or downregulated at P17 (neovascularization) OIR compared to control retinas at P17 (adjusted P value
< 0.05). † ¼ protein quantification based on only one specific peptide. ‡ ¼ proteins that had significant Levene’s test results (P value < 0.05),
suggesting potential issues with t-test assumptions. For these proteins, the statistical significance was checked also with Wilcoxon rank sum test and
results were deemed statistically significant.
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FIGURE 5. Differentially expressed proteins in OIR during hypoxia and angiogenesis. Mice pups were exposed to hyperoxia-induced OIR, and
retinas were harvested at P13, P17, and P42. All retina samples were analyzed by MS-SWATH and the data underwent statistical analysis to compare
control and OIR samples in each time point. The means and standard error bars are shown for control (red) and OIR (blue) samples for chosen
proteins during hypoxia at P13 (A) and at the peak of neovascularization at P17 (B). The asterisks identify statistically significant differences
between the two groups before P value adjustment (*), and after P value (**) adjustment. Note that Glul (A) is different both at P13 and at P17. (C)
Western blot membrane immunoblotted with anti-Flna antibody shows increased Flna expression at P17 OIR and hypoxia-induced cleavage of C-
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for proteins with nonadjusted P value (P < 0.05) as statistically
significant (Supplementary Table S3). IPA analysis revealed
decreased neurotransmission (P¼ 6.56E-05, activation score¼
2) at P42 OIR compared to control retinas as the only
significant difference between the groups. Altogether, 11
proteins in neurotransmission were involved (Supplementary
Fig. S4A) and further examination revealed changes in the
synaptic vesicle cycle pathway (KEGG) (Supplementary Fig.
S4B). Selection of proteins upregulated at P42 OIR are
illustrated in Figure 8. These are proteins associated at least
with cell migration and adhesion, and retinal glial cells (Fig. 8).
DISCUSSION
We have carried out the most comprehensive proteomics
analysis of the commonly used experimental retinal angiogen-
esis model, OIR. The results reveal that in addition to the
changes detected on proteins responding to hypoxia and those
regulating angiogenesis, some changes in protein expression
take place in the neuronal tissue of the retina. This is in
accordance with the fact that human retinal vascular diseases
are associated with neuropathy and gliopathy. Furthermore,
the dysregulation of the cross talk between vasculature and
retinal neuroglia and neuronal cells has been shown to
contribute to the pathogenesis of DR.23–25
During the hypoxic phase, the most upregulated proteins
were crystallins, which are small heat shock proteins that act
as molecular chaperones by binding misfolded proteins to
prevent their denaturation and aggregation.26,27 They protect
cells from hypoxia and maintain mitochondrial integrity.26,28 In
addition to their neuroprotective role, crystallins also have
other roles in vascular biology.29,30 aB-crystallin functions as a
chaperone for VEGFA and is crucial for its proper secretion,
which in turn, is crucial for endothelial cell survival in
hypoxia.28,31,32 Thus, aB-crystallin knockout mice had less
VEGFA and neovascularization than WT in OIR.31 In the eye,
crystallins were originally characterized as abundant lens
proteins, but they are also expressed in developing and mature
retina.28,32–34 Their expression is dramatically upregulated in
numerous retinal diseases, such as mechanical injury, ischemic
insults, age-related macular degeneration (AMD), uveoretinitis,
and DR.28 Concerning the potential therapeutic value of
crystallins in retinal diseases, their exact functions are
emerging.27,35 Namely, the recently discovered roles for aB–
crystallin in mediating TGF-b induced epithelial-mesenchymal
transformation (EMT) and subretinal fibrosis in AMD,27 while
aA–crystallin providing neuroprotection for retina in DR,35
point out the opposite therapeutic values for these crystallin-
family members.27,36
A large number of proteins was also downregulated in
response to hypoxia in retina. Among these proteins were
Cnga1, Gucy2e, Rom1, and Grk1, proteins associated with
phototransduction. Since rod photoreceptors are the most
oxygen-dependent cells in the retina,37 the downregulation of
proteins associated with rod function is a plausible outcome in
hypoxia.
FIGURE 6. Myh9 is expressed in retinal blood vessels and induced by angiogenesis during OIR. (A) Control and OIR retinas were processed for IHC
and stained for nonmuscle myosin IIA (Myh9) as described in the Materials and Methods section. Myh9 expression is confined to blood vessels in
normal retina at P17. Strong Myh9 is induced in the angiogenic blood vessels at the peak of angiogenesis in OIR retina at P17. (B) Double-IF stainings
for Myh9 and endothelial cells (CD31) (B) and Myh9 and pericytes (NG2) (C) confirmed that the Myh9 expression comes from endothelial cells and
from some of the pericytes in OIR retina at P17. Arrows (C) are pointing to pericytes that do not express Myh9. GCL, ganglion cell layer; IPL, inner
plexiform layer; INL, inner nuclear layer, OPL, outer plexiform layer; ONL, outer nuclear layer; IS/OS, photoreceptor inner/outer segments. Scale
bars represent 50 lm in panel A and 20 lm in panels B and C.
terminal fragment of Flna (FlnaCT). (D) Densitometric quantification revealed 4.6-fold induction in total Flna protein levels, while FlnaCT levels were
increased 14-fold at P17 OIR compared to P17 control samples. (E, F) Western blotting against Myh9 and densitometric quantification showed 9.6-
fold induction at P17 OIR compared to P17 control samples. (*P < 0.05; **P < 0.01; ***P < 0.001) (G) Control and OIR retinas collected at P17 were
processed for immunohistochemical analysis and stained for Flna and Myh9 as described in the Materials and Methods section. Both Flna and Myh9
expression is increased in OIR retinas compared to controls. Strong expression of Flna and Myh9 can be seen from preretinal tufts (arrows) and
from the blood vessels in inner retina in OIR. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer, OPL, outer plexiform
layer; ONL, outer nuclear layer; IS/OS, photoreceptor inner/outer segments; RPE, retinal pigment epithelium. Scale bars represent 200 lm. † ¼
protein quantification based on only one specific peptide. ‡¼ statistical significance was checked also with Wilcoxon rank sum test due to positive
Levene’s test results.
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The most abundant changes in the retinal protein expres-
sion in OIR were seen at the peak of neovascularization at P17.
Among the most upregulated proteins were plasma proteins
Ahsg, Gc, Apoa1, Alb, and Tf (Supplementary Table S2). This is
most probably due to increased permeability of the angiogenic
blood vessels, which leads to the accumulation of plasma
proteins in retinal tissue by leakage. However, some of these
proteins could also have relevant biological functions, not just
be bystanders by leakage, in OIR. Fetuin-A (Ahsg) as well as its
cellular receptors, Anxa2 and -6, were highly upregulated in
OIR. Fetuin-A is an adhesive glycoprotein that binds to Anxa2
and -6 and induces cell proliferation in its target cells.38 Anxa2,
in turn, drives angiogenesis in OIR.38 Gc is a multifunctional
glycoprotein that acts as a carrier protein for vitamin D but can
also modulate certain immune and inflammatory responses.39
Vitamin D, in turn, is known to inhibit retinal neovasculariza-
tion in OIR,40 and vitamin D receptor agonists inhibit
developmental retinal angiogenesis.41 Thus, the accumulation
of Gc by the leakage from the angiogenic blood vessels could
be a natural, endogenous signal to suppress angiogenesis at the
time angiogenesis reaches its peak in OIR.
In line with the extensive angiogenesis taking place in
retina at P17, IPA analysis revealed proteins ‘‘related to
angiogenesis’’ being the most significantly upregulated pro-
teins. Among these proteins were Filamins, Flna and Flnb. In
hypoxia, oxygen-sensing prolyl hydroxylase domain protein 2
(PHD2) inactivation rapidly upregulates Flna expression.42
Flna, in turn, interacts physically with HIF-1a and promotes
angiogenesis.43 Hypoxia induces calpain-dependent cleavage
of Flna, and its C-terminal fragment (FlnaCT) accumulates in the
nucleus and facilitates the nuclear localization of HIF-1a.43 Our
study shows that hypoxia induces Flna cleavage, that is, FlnaCT
FIGURE 7. Myh9 is strongly expressed in human PDR and RVO fibrovascular membranes. Adjacent sections of fibrovascular membranes obtained
from pars plana vitrectomies from PDR and RVO patients were stained for blood vessels (CD31), Myh9, and HSA. (A) Rather faint Myh9 expression
was restricted to the blood vessels while almost no HSA accumulation was seen outside of the blood vessels in some PDR samples [PDR (i)]. Strong
Myh9 expression was seen not only in the blood vessels, but also in the cells outside of the blood vessels and HSA had accumulated into the
fibrovascular membrane’s extracellular matrix in some PDR cases [PDR (ii)] as a sign of prominent vascular leakage. Especially strong Myh9
expression as well as substantial HSA accumulation were seen throughout the RVO sample, where strong fibrosis formation has taken place. (B)
High magnification images from PDR patient (iii) show strong Myh9 expression in the highly vascularized area where HSA has leaked into the
extracellular matrix (arrows). Scale bars represent 200 lm in panel A and 100 lm in panel B. M, male; F, female.
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generation in OIR. Very recently it was shown that blocking
the calpain-dependent cleavage of Flna impairs tumor cell
proliferation and migration.44 Furthermore, it is worth noting
that Flna also interacts with small GTPase, R-Ras,45,46 the
master regulator of vascular permeability in angiogenesis46–50
and the gene needed for proper endothelial lumenogenesis.51
The interaction between Flna and R-Ras is crucial for
controlling vascular permeability in angiogenesis.45,46 R-Ras,
in turn, regulates vascular permeability in OIR and the reduced
expression of R-Ras is associated with vascular leakage in
PDR.16 The interaction between R-Ras and Flna takes place
with the N-terminal part of Flna.45 Thus, selective blocking of
the C-terminal cleavage of Flna (FlnaCT) could potentially be
therapeutic in ischemic retinal diseases with pathological
angiogenesis.
Another angiogenesis-related protein that stands out is
Myh9. Myh9 gene encodes for Myosin 9, a heavy chain of
Myosin IIA, a cytoskeletal contractile protein.52 In general, the
expression levels of Myh9 reflect the stiffness of the tissue;
cells in stiff tissues express plenty of Myh9, while the cells in
nonstiff tissues express low levels of Myh9.19–21 In addition to
the stiffness of the tissue, cell migration induces high
mechanical strains on the cells as their ‘‘pierce’’ through
extracellular matrix. Thus, the migrating cells upregulate the
expression of Myh9 to make themselves more rigid to
withstand the mechanical forces placed on them during the
migratory process,19–21 but their enhanced contractility
destabilizes endothelial cell–cell junctions and impairs endo-
thelial barrier function, resulting in increased vascular perme-
ability.22,53,54 Angiogenesis is essentially a cell migratory
process and as shown in this study, the upregulation of the
Myh9 takes place in the angiogenic endothelial cells in the
retina. Thus, the induction of Myh9 during the peak of
angiogenesis in OIR is plausible phenomenon, but could also
be highly relevant as the increased vascular leakage is a
hallmark in OIR. We also studied samples obtained from human
PDR and RVO patients and showed that the vascular leakage in
these diseases correlates with the amount of Myh9 expression
in this area. Endothelial cell contractility (i.e., enhanced Myh9
expression) increases not only with cell migration, but also
with the increased matrix stiffness resulting in increased
endothelial permeability due to impaired endothelial barrier
function.22,53–55 Thus, the changes in matrix stiffness and the
resultant endothelial cell contractility could be highly relevant
for large number of neovascular retinal diseases associated
with pathological leakage from the blood vessels.
Myh9 also regulates angiogenesis via controlling the
production of VEGFA in ischemia-driven arteriogenesis56 as
well as controlling nucleolin translocalization.57 Nucleolin is
primarily a nuclear protein that translocates to cell surface in
angiogenesis.57–59 The different antagonists of nucleolin,
among them Myh9 antibodies, have been shown to inhibit
tumor angiogenesis by stabilizing the pathological vascula-
ture,57,59 which enhances tissue oxygenation.59 The modest
increase (log2 FC 0.23) in nucleolin expression seen by MS in
OIR at P17 suggests that the effects of nucleolin in
angiogenesis is merely related to its translocation from nucleus
to cell surface than increase in its expression level.
The present proteomics approach quantifies complete
expression pattern of almost 3000 proteins and thus provides
strong value to identify pathways involved in OIR. Using the
upstream regulator analysis with IPA, the most potential and
activated upstream regulator driving angiogenesis was TGF-b1.
This is in accordance with previous studies showing TGF-b1
upregulation in OIR.60 Interestingly, conditional ocular dele-
tions of TGF-b signaling results in pronounced structural
changes of retinal capillaries and a phenotype similar to human
DR.61,62 The upstream regulator analysis identified Mkl2 and
FIGURE 8. Selection of upregulated proteins at P42 OIR. Mice were exposed to OIR, and control and OIR retinas were harvested at P13, P17, and
P42. Samples were analyzed by MS-SWATH, and the data underwent statistical analysis to compare control and OIR samples. The means and
standard error bars are shown for control (red) and OIR (blue) samples for chosen proteins involved in cell migration and adhesion (Fgf2, Anxa5,
CD44) and retinal glial cells (Gfap). Rbp3 has a critical role in visual cycle. The asterisks identify statistically significant differences between the two
groups before P value adjustment (P value < 0.05).
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Mknk1 as enhancers of angiogenesis in OIR. Mkl2, a
transcriptional coactivator, regulates conserved TGF-b signal-
ing pathway.63 Mice deficient for Mkl2 die at the early
embryonic state, and Mkl2/ ECs have defects in cytoskeletal
organization and cell adhesion.63 Mkl2/TGF-b pathway is
required for the maturation and stabilization of embryonic
vasculature,63–65 but also for the myofibroblast transformation
and EMT induction.66,67 The enhanced TGF-b signaling taking
place in vasculature leads to the endothelial-mesenchymal
transition (EndMT), a process that has many similarities with
EMT.68,69 The transformed endothelial cells have high vascular
permeability, further driving inflammation and by thus
perpetuating the incomplete repair state.69 This inflamma-
tion–TGF-b circuit in vasculature also promotes fibrosis in the
surrounding tissue, and it is largely irreversible.68,69 The
recently identified association between TGF-b signaling and
ab-crystallin in the EMT and subretinal scarring,27 the massive
induction of crystallins by hypoxia and the subsequent
activation of TGF-b/Mkl2-signaling pathways in OIR provide
clues about the potential interplay that leads to retinal fibrosis
in the human neovascular diseases of retina.
Another upstream regulator potentially enhancing angio-
genesis in OIR is Mknk1/MNK1. Mknk1 is a kinase that
exclusively phosphorylates a cap-binding subunit of the eIF4F
translation initiation complex, elF4E, and selectively facilitating
translation of proliferation, migration, and survival promoting
mRNAs, among them VEGFA.70 Inhibition of eIF4E phosphor-
ylation, in turn, suppressed angiogenesis.71 In retina, eIF4E
interacts with 4E-bp1, which expression is enhanced in retina
by diabetes-induced hyperglycemia and necessary for VEGFA
expression.72,73 Our results suggest that blocking MNK-eIF4E
pathway could be a potential target for blocking pathological
angiogenesis in retinal diseases.
We included the late OIR-time point, P42, in our study to
assess whether hypoxic exposure and subsequent neovascu-
larization cause permanent changes in the protein expression
in the retina. Very little is known about the long-term effects of
OIR on retina, although the information could be useful to
understand the prognosis of ROP. The disruption of the retinal
morphology as well as decrease in neuronal function have
been reported after OIR.74 Our IPA analysis revealed decreased
neurotransmission at P42 OIR retinas. Further examination
revealed changes in the synaptic vesicle cycle pathway (KEGG)
(Supplementary Fig. S4).
The present proteomics analysis revealed novel pathways
that might contribute to the development of pathological
angiogenesis in OIR. Furthermore, we were able to identify
molecular interplay between the proteins induced by hypoxia
and then by subsequent angiogenesis in OIR. They could be
potential druggable targets of retinal diseases inflected with
hypoxia and neovascularization.
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